GYN

UTERINE

  • GOG 0238 - A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients with Pelvic Only Recurrence of Carcinoma of the Uterine Corpus
  • GOG 0275- A Randomized Phase III Study of Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
  • GOG 0277- A Randomized Phase III Study of  Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

ENDOMETRIAL

  • RTOG 1203- A Randomized Phase III Study of Standard vs. Intensity-Modulated Pelvic Radiation Therapy For Post-Operative Treatment of Endometrial and Cervical Cancer
  • GOG 0286B- A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy forMeasurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer

CERVIX

  • GOG 0263 - Randomized Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy
  • RTOG 1203- A Randomized Phase III Study of Standard vs. Intensity-Modulated Pelvic Radiation Therapy For Post-Operative Treatment of Endometrial and Cervical Cancer
  • RTOG 0724- A Randomized Phase III Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy (Temporary Closure)
  • GOG 0274- A Randomized Phase III Study of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

OVARIAN/FALLOPIAN TUBE

  • GOG 0261- A Randomized Phase III Study of Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
  • GOG 0213- A Randomized Phase III Study of Carboplatin and Paclitaxel (or Gemcitabine) with/or without Bevacizumab followed by Bevacizumab and Secondary Cytoreductuve Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary, and Fallopian Tube Cancer
  • GOG 0264- A Randomized Phase II  Study of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex-Cord Stromal Tumors of the Ovary 
  • GOG 0281- A Randomized Phase II/III Study to Assess the Efficacy of Trametinib in Patients with Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Primary Peritoneal Cancer

Vulvar

  • GOG 0270- Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study

Metastatic

  • RTOG 0631- A Randomized Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis